» Articles » PMID: 36625940

Non-coding RNAs in Human Health and Disease: Potential Function As Biomarkers and Therapeutic Targets

Overview
Publisher Springer
Date 2023 Jan 10
PMID 36625940
Authors
Affiliations
Soon will be listed here.
Abstract

Human diseases have been a critical threat from the beginning of human history. Knowing the origin, course of action and treatment of any disease state is essential. A microscopic approach to the molecular field is a more coherent and accurate way to explore the mechanism, progression, and therapy with the introduction and evolution of technology than a macroscopic approach. Non-coding RNAs (ncRNAs) play increasingly important roles in detecting, developing, and treating all abnormalities related to physiology, pathology, genetics, epigenetics, cancer, and developmental diseases. Noncoding RNAs are becoming increasingly crucial as powerful, multipurpose regulators of all biological processes. Parallel to this, a rising amount of scientific information has revealed links between abnormal noncoding RNA expression and human disorders. Numerous non-coding transcripts with unknown functions have been found in addition to advancements in RNA-sequencing methods. Non-coding linear RNAs come in a variety of forms, including circular RNAs with a continuous closed loop (circRNA), long non-coding RNAs (lncRNA), and microRNAs (miRNA). This comprises specific information on their biogenesis, mode of action, physiological function, and significance concerning disease (such as cancer or cardiovascular diseases and others). This study review focuses on non-coding RNA as specific biomarkers and novel therapeutic targets.

Citing Articles

Whole transcriptome analysis in oviduct provides insight into microRNAs and ceRNA regulative networks that targeted reproduction of goat (Capra hircus).

Liu Q, Sun Z, Liu Y, He X, Ren C, Wang X BMC Genomics. 2025; 26(1):250.

PMID: 40087554 DOI: 10.1186/s12864-025-11438-8.


Emerging Roles of Long Non-Coding RNAs in Cardiovascular Diseases.

Kong X, Li F, Wang Y J Cell Mol Med. 2025; 29(5):e70453.

PMID: 40032652 PMC: 11875779. DOI: 10.1111/jcmm.70453.


Mechanisms for Orofacial Pain: Roles of Immunomodulation, Metabolic Reprogramming, Oxidative Stress and Epigenetic Regulation.

Khan S, Tao F Biomedicines. 2025; 13(2).

PMID: 40002847 PMC: 11853523. DOI: 10.3390/biomedicines13020434.


Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).

Guo X, Li S Oncol Rep. 2025; 53(4).

PMID: 39981932 PMC: 11865881. DOI: 10.3892/or.2025.8879.


References
1.
Hagemann-Jensen M, Abdullayev I, Sandberg R, Faridani O . Small-seq for single-cell small-RNA sequencing. Nat Protoc. 2018; 13(10):2407-2424. DOI: 10.1038/s41596-018-0049-y. View

2.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

3.
Sahin U, Oehm P, Derhovanessian E, Jabulowsky R, Vormehr M, Gold M . An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020; 585(7823):107-112. DOI: 10.1038/s41586-020-2537-9. View

4.
Liebow A, Li X, Racie T, Hettinger J, Bettencourt B, Najafian N . An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria. J Am Soc Nephrol. 2016; 28(2):494-503. PMC: 5280024. DOI: 10.1681/ASN.2016030338. View

5.
Salvatore M, Magrelli A, Taruscio D . The role of microRNAs in the biology of rare diseases. Int J Mol Sci. 2011; 12(10):6733-42. PMC: 3211006. DOI: 10.3390/ijms12106733. View